Literature DB >> 20435781

Killing of non-replicating Mycobacterium tuberculosis by 8-hydroxyquinoline.

Crystal M Darby1, Carl F Nathan.   

Abstract

OBJECTIVES: To determine the effect of 8-hydroxyquinoline (8HQ) on non-replicating Mycobacterium tuberculosis (Mtb) in comparison with its reported effect on replicating Mtb.
METHODS: The MIC of 8HQ for replicating H37Rv Mtb was determined by microdilution in 7H9 broth. Bactericidal activity was determined by exposing H37Rv Mtb to 8HQ for 4 days under conditions that otherwise allowed exponential replication (20% O(2), pH 6.6) and conditions under which replication was precluded: 1% O(2), pH 6.6; 20% O(2), pH 5.5; or 20% O(2), pH 5.5, 0.5 mM sodium nitrite. Serial dilutions were plated on 7H11 agar to quantify cfu. Frequency of resistance (FOR) was determined with >10(9) bacteria plated on 7H9 agar plates containing 2x MIC 8HQ.
RESULTS: 8HQ was active against replicating Mtb (MIC 2.5 microM, 0.36 mg/L). Under both replicating and non-replicating conditions, cfu were reduced in 4 days by > or = 5 log(10) at the highest concentration tested (10 microM). Bactericidal activity was maximal at low pH, where 8HQ reduced cfu by 1-1.5 log(10) at 1 microM. We were unable to recover any 8HQ-resistant colonies.
CONCLUSIONS: This study demonstrates that 8HQ has bactericidal activity of comparable potency against non-replicating and replicating Mtb, a property not observed for anti-infective agents currently approved for treatment of tuberculosis, and a very low FOR. Drugs with these properties are urgently needed to shorten the course of treatment for both active and latent tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20435781     DOI: 10.1093/jac/dkq145

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  22 in total

1.  8-Hydroxyquinolines Are Boosting Agents of Copper-Related Toxicity in Mycobacterium tuberculosis.

Authors:  Santosh Shah; Alex G Dalecki; Aruni P Malalasekera; Cameron L Crawford; Suzanne M Michalek; Olaf Kutsch; Jim Sun; Stefan H Bossmann; Frank Wolschendorf
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

2.  A small molecule screen identifies selective inhibitors of urea transporter UT-A.

Authors:  Cristina Esteva-Font; Puay-Wah Phuan; Marc O Anderson; A S Verkman
Journal:  Chem Biol       Date:  2013-09-19

3.  Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials.

Authors:  Ben Gold; Maneesh Pingle; Steven J Brickner; Nilesh Shah; Julia Roberts; Mark Rundell; W Clay Bracken; Thulasi Warrier; Selin Somersan; Aditya Venugopal; Crystal Darby; Xiuju Jiang; J David Warren; Joseph Fernandez; Ouathek Ouerfelli; Eric L Nuermberger; Amy Cunningham-Bussel; Poonam Rath; Tamutenda Chidawanyika; Haiteng Deng; Ronald Realubit; J Fraser Glickman; Carl F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-10       Impact factor: 11.205

Review 4.  Targeting Phenotypically Tolerant Mycobacterium tuberculosis.

Authors:  Ben Gold; Carl Nathan
Journal:  Microbiol Spectr       Date:  2017-01

5.  Exploiting innate immune cell activation of a copper-dependent antimicrobial agent during infection.

Authors:  Richard A Festa; Marian E Helsel; Katherine J Franz; Dennis J Thiele
Journal:  Chem Biol       Date:  2014-07-31

6.  8-Hydroxyquinoline Glycoconjugates: Modifications in the Linker Structure and Their Effect on the Cytotoxicity of the Obtained Compounds.

Authors:  Monika Krawczyk; Gabriela Pastuch-Gawołek; Aleksandra Pluta; Karol Erfurt; Adrian Domiński; Piotr Kurcok
Journal:  Molecules       Date:  2019-11-18       Impact factor: 4.411

Review 7.  Targeting persisters for tuberculosis control.

Authors:  Ying Zhang; Wing Wai Yew; Michael R Barer
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

Review 8.  8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications.

Authors:  Veda Prachayasittikul; Supaluk Prachayasittikul; Somsak Ruchirawat; Virapong Prachayasittikul
Journal:  Drug Des Devel Ther       Date:  2013-10-04       Impact factor: 4.162

9.  Rapid, Semiquantitative Assay To Discriminate among Compounds with Activity against Replicating or Nonreplicating Mycobacterium tuberculosis.

Authors:  Ben Gold; Julia Roberts; Yan Ling; Landys Lopez Quezada; Jou Glasheen; Elaine Ballinger; Selin Somersan-Karakaya; Thulasi Warrier; J David Warren; Carl Nathan
Journal:  Antimicrob Agents Chemother       Date:  2015-08-03       Impact factor: 5.191

10.  Optimization and Evaluation of 5-Styryl-Oxathiazol-2-one Mycobacterium tuberculosis Proteasome Inhibitors as Potential Antitubercular Agents.

Authors:  Francesco Russo; Johan Gising; Linda Åkerbladh; Annette K Roos; Agata Naworyta; Sherry L Mowbray; Anders Sokolowski; Ian Henderson; Torey Alling; Mai A Bailey; Megan Files; Tanya Parish; Anders Karlén; Mats Larhed
Journal:  ChemistryOpen       Date:  2015-04-17       Impact factor: 2.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.